PPD Acquires Acurian

Pharmaceutical Product Development (PPD), has acquired Acurian, a service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.

Providing analytics-driven services to large and mid-sized pharmaceutical companies, Acurian manages the patient recruitment, enrollment, and retention. The company uses software analytics to customize approaches for recruiting patients for a customer’s clinical trial.

Acurian will continue to operate under its own name as a separate business unit with its existing management team led by Rick Malcolm, who has served as Acurian’s CEO since 2005.

Source:

Pharmaceutical Product Development